GSE165548 gemcitabine 2 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE165548_gemcitabine_2_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE165548_gemcitabine_2_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE165548_gemcitabine_2_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE165548_gemcitabine_2_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

CHD9 neighbor

Gene

uncharacterized LOC100506474

Gene

uncharacterized LOC101927745

Gene

C1QTNF1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 592

Gene

long intergenic non-protein coding RNA 2869

Gene

long intergenic non-protein coding RNA 1331

Gene

uncharacterized LOC107986453

Gene

long intergenic non-protein coding RNA 3209

Gene

chaperonin containing TCP1 subunit 7 pseudogene 2


  • Gene

    uncharacterized LOC100506474


  • Gene

    uncharacterized LOC101927745


  • Gene

    C1QTNF1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 592


  • Gene

    long intergenic non-protein coding RNA 2869


  • Gene

    long intergenic non-protein coding RNA 1331


  • Gene

    uncharacterized LOC107986453


  • Gene

    long intergenic non-protein coding RNA 3209


  • Gene

    chaperonin containing TCP1 subunit 7 pseudogene 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.